238 related articles for article (PubMed ID: 25869099)
1. B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3.
Fei F; Joo EJ; Tarighat SS; Schiffer I; Paz H; Fabbri M; Abdel-Azim H; Groffen J; Heisterkamp N
Oncotarget; 2015 May; 6(13):11378-94. PubMed ID: 25869099
[TBL] [Abstract][Full Text] [Related]
2. Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia.
Tarighat SS; Fei F; Joo EJ; Abdel-Azim H; Yang L; Geng H; Bum-Erdene K; Grice ID; von Itzstein M; Blanchard H; Heisterkamp N
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830047
[TBL] [Abstract][Full Text] [Related]
3. Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008.
Paz H; Joo EJ; Chou CH; Fei F; Mayo KH; Abdel-Azim H; Ghazarian H; Groffen J; Heisterkamp N
J Exp Clin Cancer Res; 2018 Mar; 37(1):67. PubMed ID: 29580262
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
[TBL] [Abstract][Full Text] [Related]
5. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
[TBL] [Abstract][Full Text] [Related]
6. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
[TBL] [Abstract][Full Text] [Related]
7. Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia.
Fei F; Zhang M; Tarighat SS; Joo EJ; Yang L; Heisterkamp N
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430839
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth.
Narendran A; Ganjavi H; Morson N; Connor A; Barlow JW; Keystone E; Malkin D; Freedman MH
Exp Hematol; 2003 Aug; 31(8):693-701. PubMed ID: 12901974
[TBL] [Abstract][Full Text] [Related]
9. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells.
Portale F; Cricrì G; Bresolin S; Lupi M; Gaspari S; Silvestri D; Russo B; Marino N; Ubezio P; Pagni F; Vergani P; Kronnie GT; Valsecchi MG; Locatelli F; Rizzari C; Biondi A; Dander E; D'Amico G
Haematologica; 2019 Mar; 104(3):533-545. PubMed ID: 30262563
[TBL] [Abstract][Full Text] [Related]
10. Identification of galectin-3-binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma.
Fukaya Y; Shimada H; Wang LC; Zandi E; DeClerck YA
J Biol Chem; 2008 Jul; 283(27):18573-81. PubMed ID: 18450743
[TBL] [Abstract][Full Text] [Related]
11. Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity.
Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500796
[TBL] [Abstract][Full Text] [Related]
12. Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia.
George AA; Paz H; Fei F; Kirzner J; Kim YM; Heisterkamp N; Abdel-Azim H
PLoS One; 2015; 10(9):e0137917. PubMed ID: 26360058
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 initiates epithelial-stromal paracrine signaling to shape the proteolytic microenvironment during corneal repair.
AbuSamra DB; Mauris J; Argüeso P
Sci Signal; 2019 Jul; 12(590):. PubMed ID: 31311846
[TBL] [Abstract][Full Text] [Related]
14. The deficiency of galectin-3 in stromal cells leads to enhanced tumor growth and bone marrow metastasis.
Pereira JX; Azeredo MC; Martins FS; Chammas R; Oliveira FL; Santos SN; Bernardes ES; El-Cheikh MC
BMC Cancer; 2016 Aug; 16():636. PubMed ID: 27526676
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
16. Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors.
Valach J; Fík Z; Strnad H; Chovanec M; Plzák J; Cada Z; Szabo P; Sáchová J; Hroudová M; Urbanová M; Steffl M; Pačes J; Mazánek J; Vlček C; Betka J; Kaltner H; André S; Gabius HJ; Kodet R; Smetana K; Gál P; Kolář M
Int J Cancer; 2012 Dec; 131(11):2499-508. PubMed ID: 22447203
[TBL] [Abstract][Full Text] [Related]
17. Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents.
Furuichi Y; Goi K; Inukai T; Sato H; Nemoto A; Takahashi K; Akahane K; Hirose K; Honna H; Kuroda I; Zhang X; Kagami K; Hayashi Y; Harigaya K; Nakazawa S; Sugita K
Cancer Res; 2007 Oct; 67(20):9852-61. PubMed ID: 17942916
[TBL] [Abstract][Full Text] [Related]
18. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.
Shekhar MP; Nangia-Makker P; Tait L; Miller F; Raz A
Am J Pathol; 2004 Dec; 165(6):1931-41. PubMed ID: 15579437
[TBL] [Abstract][Full Text] [Related]
19. B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment.
Polak R; de Rooij B; Pieters R; den Boer ML
Blood; 2015 Nov; 126(21):2404-14. PubMed ID: 26297738
[TBL] [Abstract][Full Text] [Related]
20. Lack of galectin-3 modifies differentially Notch ligands in bone marrow and spleen stromal cells interfering with B cell differentiation.
de Oliveira FL; Dos Santos SN; Ricon L; da Costa TP; Pereira JX; Brand C; Fermino ML; Chammas R; Bernardes ES; El-Cheikh MC
Sci Rep; 2018 Feb; 8(1):3495. PubMed ID: 29472568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
